Key points are not available for this paper at this time.
Thus, Metrnl may be an attractive therapeutic target or regimen for treating DCM.
Lu et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: